Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis

Human Reproduction

Volumn 26, Issue 2, 2011, Pages 337-345

  Liu, Xishi ^a   Nie, Jichan ^a   Guo, Sun Wei ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

adenomyosis; heavy menstrual bleeding; immunohistochemistry; severity of dysmenorrhea; tissue factor

Indexed keywords

THROMBOPLASTIN;

ADENOMYOSIS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; HUMAN; HUMAN TISSUE; HYPERMENORRHEA; IMMUNOREACTIVITY; MENSTRUATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 79251507969     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq311     Document Type: Article

References (77)

1. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, Milbrandt J. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000;31:443-447.
2. Bagrodia S, Bailey D, Lenard Z, Hart M, Guan JL, Premont RT, Taylor SJ, Cerione RA. A tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins. J Biol Chem 1999;274:22393-22400.
3. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:511-521.
4. Bergmann A, Agapite J, McCall K, Steller H. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell 1998; 95:331-341.
5. Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol 1972;112:583-593.
6. Camerer E, Rottingen JA, Gjernes E, Larsen K, Skartlien AH, Iversen JG, Prydz H. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 1999;274:32225-32233.
7. Cinar O, Seval Y, Uz YH, Cakmak H, Ulukus M, Kayisli UA, Arici A. Differential regulation of Akt phosphorylation in endometriosis. Reprod Biomed Online 2009;19:864-871.
8. Cirpan T, Yeniel O, Ulukus M, Ozbal A, Gundem G, Ozsener S, Mete Itil I, Zekioglu O. Clinical symptoms and histopathological findings in subjects with adenomyosis uteri. Clin Exp Obstet Gynecol 2008;35:48-53.
9. Critchley HO, Kelly RW, Baird DT, Brenner RM. Regulation of human endometrial function: mechanisms relevant to uterine bleeding. Reprod Biol Endocrinol 2006;4(Suppl. 1):S5.
10. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 2000;87:434-439.
11. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 2005;11:63-70.
12. Erlich J, Parry GC, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci USA 1999; 96:8138-8143.
13. Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:603-616.
14. Fitzgibbon J, Morrison JJ, Smith TJ, O'Brien M. Modulation of human uterine smooth muscle cell collagen contractility by thrombin, Y-27632, TNF alpha and indomethacin. Reprod Biol Endocrinol 2009;7:2.
15. Fraser IS, Hickey M. Endometrial vascular changes and bleeding disturbances with long-acting progestins. Steroids 2000;65:665-670.
16. Goteri G, Ciavattini A, Lucarini G, Montik N, Filosa A, Stramazzotti D, Biagini G, Tranquilli AL. Expression of motility-related molecule Cdc42 in endometrial tissue in women with adenomyosis and ovarian endometriomata. Fertil Steril 2006;86:559-565.
17. Grow DR, Filer RB. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol 1991;78:538-539.
18. Grund EM, Kagan D, Tran CA, Zeitvogel A, Starzinski-Powitz A, Nataraja S, Palmer SS. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells. Mol Pharmacol 2008;73:1394-1404.
19. Harada M, Osuga Y, Hirota Y, Koga K, Morimoto C, Hirata T, Yoshino O, Tsutsumi O, Yano T, Taketani Y. Mechanical stretch stimulates interleukin-8 production in endometrial stromal cells: possible implications in endometrium-related events. J Clin Endocrinol Metab 2005;90:1144-1148.
20. Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O, Koga K, Yano T, Tsutsumi O, Taketani Y. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 2005; 20:3547-3553.
21. Houston P, Dickson MC, Ludbrook V, White B, Schwachtgen JL, McVey JH, Mackman N, Reese JM, Gorman DG, Campbell C et al. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler Thromb Vasc Biol 1999; 19:281-289.
22. Inhaka R, Gentleman RR. R: a language for data analysis and graphics. J comput Graph Statist 1996;5:1923-1927.
23. Johnson MC, Torres M, Alves A, Bacallao K, Fuentes A, Vega M, Boric MA. Augmented cell survival in eutopic endometrium from women with endometriosis: expression of c-myc, TGF-beta1 and bax genes. Reprod Biol Endocrinol 2005;3:45.
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley, 1980.
25. Kilkku P, Erkkola R, Gronroos M. Non-specificity of symptoms related to adenomyosis. A prospective comparative survey. Acta Obstet Gynecol Scand 1984;63:229-231.
26. Kim SH, Lee HW, Kim YH, Koo YH, Chae HD, Kim CH, Lee PR, Kang BM. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis. Hum Reprod 2009;24:1133-1141.
27. Kim SR, Kim SH, Lee HW, Chae HD, Kim CH, Kang BM. Increased expression of p21-activated kinase in adenomyosis. Fertil Steril 2010; 94:1125-1128.
28. Kissler S, Hamscho N, Zangos S, Wiegratz I, Schlichter S, Menzel C, Doebert N, Gruenwald F, Vogl TJ, Gaetje R et al. Uterotubal transport disorder in adenomyosis and endometriosis-a cause for infertility. BJOG 2006;113:902-908.
29. Kitawaki J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol 2006;20:493-502.
30. Konno R, Fujiwara H, Netsu S, Odagiri K, Shimane M, Nomura H, Suzuki M. Gene expression profiling of the rat endometriosis model. Am J Reprod Immunol 2007;58:330-343.
31. Koomagi R, Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 1998;79:19-22.
32. Krikun G, Schatz F, Mackman N, Guller S, Lockwood CJ. Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells. J Clin Endocrinol Metab 1998;83:926-930.
33. Krikun G, Schatz F, Mackman N, Guller S, Demopoulos R, Lockwood CJ. Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Mol Endocrinol 2000; 14:393-400.
34. Krikun G, Schatz F, Taylor H, Lockwood CJ. Endometriosis and tissue factor. Ann N Y Acad Sci 2008;1127:101-105.
35. Krikun G, Lockwood CJ, Paidas MJ. Tissue factor and the endometrium: from physiology to pathology. Thromb Res 2009;124:393-396.
36. Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A et al. The immunoconjugate 'icon' targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol 2010;176:1050-1056.
37. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005; 20:2309-2316.
38. Kunz G, Herbertz M, Beil D, Huppert P, Leyendecker G. Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online 2007;15:681-685.
39. Laudanski P, Szamatowicz J, Kowalczuk O, Kuzmicki M, Grabowicz M, Chyczewski L. Expression of selected tumor suppressor and oncogenes in endometrium of women with endometriosis. Hum Reprod 2009;24:1880-1890.
40. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000;95:688-691.
41. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 280:529-538.
42. Liu X, Guo SW. Dysmenorrhea: risk factors in women with endometriosis. Womens Health (Lond Engl) 2008;4:399-411.
43. Lockwood CJ, Krikun G, Hickey M, Huang SJ, Schatz F. Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding. Reprod Sci 2009;16:162-170.
44. Maia H Jr., Maltez A, Studart E, Athayde C, Coutinho EM. Effect of menstrual cycle and hormonal treatment on ki-67 and bcl-2 expression and adenomyosis. Gynecol Endocrinol 2005;20:127-131.
45. Matalliotakis IM, Kourtis AI, Panidis DK. Adenomyosis. Obstet Gynecol Clin North Am 2003;30:63-82, viii.
46. Matsuzaki S, Canis M, Vaurs-Barriere C, Boespflug-Tanguy O, Dastugue B, Mage G. DNA microarray analysis of gene expression in eutopic endometrium from patients with deep endometriosis using laser capture microdissection. Fertil Steril 2005;84(Suppl. 2):1180-1190.
47. McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998;4:350-359.
48. McCullagh P. Regression models for ordinal data (with discusssion). J Royal Stat Soc B 1980;42:109-142.
49. Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril 2009;92:886-889.
50. Nie J, Liu X, Guo SW. Immunoreactivity of oxytocin receptor and : transient receptor potential vanilloid type 1 and its correlation with; dysmenorrhea in adenomyosis. Am J Obstet Gynecol 2010a;202:346:e341-348.
51. Nie J, Liu XS, Guo SW. Increased immunoreactivity to SLIT/ROBO1 and its correlation with severity of dysmenorrhea in adenomyosis. Fertil Steril 2010b (in press).
52. Nikkanen V, Punnonen R. Clinical significance of adenomyosis. Ann Chir '■ Gynaecol 1980;69:278-280.
53. Nishida M. Relationship between the onset of dysmenorrhea and histologic findings in adenomyosis. Am J Obstet Gynecol 1991; 165:229-231.
54. O'Sullivan CJ, Allen NM, O'Loughlin AJ, Friel AM, Morrison JJ. Thrombin; and PAR1-activating peptide: effects on human uterine contractility in vitro. Am J Obstet Gynecol 2004; 190:1098-1105.
55. Ota H, Igarashi S, Hatazawa J, Tanaka T. Is adenomyosis an immune disease? Hum Reprod Update 1998;4:360-367.
56. Parrini MC, Lei M, Harrison SC, Mayer BJ. Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1. Mol Cell 2002;9:73-83.
57. Peric H, Fraser IS. The symptomatology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 2006;20:547-555.
58. Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NC, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273:6228-6232.
59. Rao LV, Pendurthi UR. Tissue factor-factor VIIa signaling. Arterioscler ', Thromb Vasc Biol 2005;25:47-56.
60. Rosai J. Female Reproductive System. Ackerman's Surgical Pathology, St. Louis: Mosby, 1989.
61. Runic R, Schatz F, Wan L, Demopoulos R, Krikun G, Lockwood CJ. Effects of norplant on endometrial tissue factor expression and blood vessel structure. J Clin Endocrinol Metab 2000;85: 3853-3859.
62. Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for; recurrence. Am J Pathol 2009;175:479-488.
63. Taniguchi F, Harada T, Miyakoda H, Iwabe T, Deura I, Tagashira Y, Miyamoto A, Watanabe A, Suou K, Uegaki T et al. TAK1 activation '. for cytokine synthesis and proliferation of endometriotic cells. Mol Cell; Endocrinol 2009;307:196-204.
64. Tsuno A, Nasu K, Yuge A, Matsumoto H, Nishida M, Narahara H. Decidualization attenuates the contractility of eutopic and ectopic endometrial stromal cells: implications for hormone therapy of endometriosis. J Clin Endocrinol Metab 2009;94:2516-2523.
65. Tukey JW. Exploratory Data Analysis. Reading, MA: Addison-Wesley, 1977.
66. Versteeg HH, HoedemaekerI, Diks SH, Stam JC, Spaargaren M,van Bergen En Henegouwen PM, van Deventer SJ, Peppelenbosch MP. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase,and Rac.JBiol Chem 2000;275:28750-28756.
67. Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling? Thromb Haemost 2001;86:1353-1359.
68. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-Habermann B, Takada Y, Mueller BM, Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008;111:190-199.
69. Wang B, Xiao Y, Ding BB, Zhang N, Yuan X, Gui L, Qian KX, Duan S, Chen Z, Rao Y et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell 2003;4:19-29.
70. Wang YJ, Wang JT, Fan QX, Geng JG. Andrographolide inhibits NF-kappaBeta activation and attenuates neointimal hyperplasia in arterial restenosis. Cell Res 2007;17:933-941.
71. Wang LJ, Zhao Y, Han B, Ma YG, Zhang J, Yang DM, Mao JW, Tang FT, Li WD, Yang Y et al. Targeting slit-roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci 2008;99:510-517.
72. Wang-Tilz Y, Tilz C, Wang B, Tilz GP, Stefan H. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy. Epilepsia 2006;47:233-239.
73. Yoshino O, Osuga Y, Hirota Y, Koga K, Hirata T, Harada M, Morimoto C, Yano T, Nishii O, Tsutsumi O et al. Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis. Am J Reprod Immunol 2004;52:306-311.
74. Yoshino O, Osuga Y, Koga K, Hirota Y, Hirata T, Ruimeng X, Na L, Yano T, Tsutsumi O, Taketani Y. FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model. J Reprod Immunol 2006;72:85-93.
75. Zhang H, Li M, Zheng X, Sun Y, Wen Z, Zhao X. Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro. Mol Hum Reprod 2009a;15:653-663.
76. Zhang X, Lu B, Huang X, Xu H, Zhou C, Lin J. Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids. Fertil Steril 2009b;92:1799-1801.
77. Zhang H, Zhao X, Liu S, Li J, Wen Z, Li M. 17betaE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB-dependent pathway. Mol Cell Endocrinol 2010;317:31-43.